Chaoju Ophthalmology Signs Multiple Strategic Agreements at CIIE to Enhance International Collaboration and Premium Eye Care Services

Original Title: CIIE Reaches Multiple Strategic Cooperations; Chaoju Eye Care Aligns with International Standards to Continuously Enhance Consumer Medical Service Levels Source: Internet

Chaoju Eye Care (02219.HK), a well-known ophthalmic medical service group, has reaped significant gains at the CIIE. As of November 8, it has successively signed strategic agreements with two major giants in the ophthalmic medical equipment and services field: Johnson & Johnson and Gao Shi.

Since its opening on November 5, the CIIE has been in full swing. Global enterprises are showcasing new products, meeting new partners, and exploring new markets, continuously creating new opportunities for the world.

Johnson & Johnson and Chaoju are both leading enterprises in the global medical and healthcare industry, with their technologies and products ranking among the best in the world. According to the agreement, Johnson & Johnson will help Chaoju access international cutting-edge technologies and accelerate the introduction of new ophthalmic technologies and products. Johnson & Johnson Vision and Chaoju Eye Care will actively promote the application of femtosecond laser cataract surgery in China and collaborate to establish a research platform for new ophthalmic technologies. At the same time, they will jointly enhance the cataract treatment skills of young and middle-aged doctors, deeply support the cataract blindness prevention public welfare initiatives in Inner Mongolia, benefiting more cataract patients. Additionally, the two parties will optimize and improve the diagnosis and treatment services for dry eye in Northern China, benefiting more patients suffering from dry eye. "Chaoju Eye Care is a leading hospital group in China that focuses on eye health. Since its establishment, it has continuously increased its influence in the industry through innovative technology, professional services, and excellent patient satisfaction. With the shared vision of 'being responsible for patients, helping them regain sight and see the world clearly,' we are delighted to further expand our cooperative relationship," said Wang Liping, Vice President of Johnson & Johnson Vision for Greater China, Australia, and New Zealand.

At the signing ceremony between Chaoju Eye Care and Johnson & Johnson Vision, Wang Liping (left), Vice President of Greater China, Australia, and New Zealand at Johnson & Johnson Vision, and Mr. Zhang Bozhou (right), Chairman of Chaoju Eye Care

Gao Shi Group and Chaoju Eye Care to Explore Multi-Party Collaborative Partnership, Jointly Promoting the Introduction of New Technologies into Chaoju Group: Both parties will actively promote advancements in femtosecond laser cataract surgery, excimer laser, ultra-widefield retinal imaging, fiber optic retinal laser, and dry eye diagnosis and treatment applications. They aim to provide cutting-edge new products and align with international technological innovations. The two sides will offer necessary resource sharing in talent development, expert resources, and academic achievements, fostering mutual benefits. The agreement also stipulates that, based on the current development status of Chaoju Group, Gao Shi will collaborate with Chaoju Group to establish a reasonable after-sales service system, providing training on equipment repair, routine maintenance, and operational precautions according to equipment usage.

It is reported that Chaoju Eye Care is a leading ophthalmic medical service group in North China and well-known across China. According to data from Frost & Sullivan, among private ophthalmic hospitals, Chaoju Eye Care ranked first in Inner Mongolia, second in North China, and fifth in China based on total revenue in 2020. Chaoju Eye Care successfully listed on the Hong Kong Stock Exchange on July 7 this year, making it one of the few publicly traded companies in the ophthalmology sector.

The cooperation with Johnson & Johnson and Gao Shi this time is expected to help Chaoju Eye Care further align with international standards, enhance the strength of medical talents, promote the iteration of medical service technologies, and gain access to more high-end international medical resources, providing more possibilities for Chaoju Eye Care to build a high-standard, international consumer ophthalmic medical service group.